lactic acid has been researched along with Pulmonary Consumption in 14 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Moreover, MET-associated lactic acidosis (MALA) needs to be considered and the incidence of MALA in patients with type 2 DM-TB coinfection remains unknown." | 9.27 | A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients. ( Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI, 2018) |
| " Moreover, MET-associated lactic acidosis (MALA) needs to be considered and the incidence of MALA in patients with type 2 DM-TB coinfection remains unknown." | 5.27 | A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients. ( Mertaniasih, NM; Novita, BD; Pranoto, A; Soediono, EI, 2018) |
| " The purpose of this study was to investigate a novel treatment for TB meant to improve patient compliance by reducing drug dosage frequency." | 1.38 | Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. ( Barata, LE; Bentley, MV; de Souza, AO; Minarini, PR; Silva, CL; Soares, EG, 2012) |
| "Therapeutic aerosol bioengineering (TAB) of Mycobacterium tuberculosis (MTb) therapies using inhalable microparticles offers a unique opportunity to target drugs to the site of infection in the alveolar macrophages, thereby increasing dosing in the lungs and limiting systemic exposure to often toxic drugs." | 1.38 | Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb). ( Cryan, SA; Dillon, P; Gallagher, PJ; Keane, J; Lawlor, C; O'Leary, S; O'Sullivan, MP; Rice, B; Shoyele, S, 2012) |
| " Relative bioavailability of encapsulated drugs was greater than that of free drugs." | 1.32 | Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis. ( Khuller, GK; Sharma, S; Ul-Ain, Q, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J | 1 |
| Chen, Z | 1 |
| Li, Y | 1 |
| Li, L | 1 |
| Zhang, G | 1 |
| Novita, BD | 1 |
| Pranoto, A | 1 |
| Soediono, EI | 1 |
| Mertaniasih, NM | 1 |
| Minarini, PR | 1 |
| de Souza, AO | 1 |
| Soares, EG | 2 |
| Barata, LE | 1 |
| Silva, CL | 3 |
| Bentley, MV | 1 |
| Lawlor, C | 1 |
| O'Sullivan, MP | 1 |
| Rice, B | 1 |
| Dillon, P | 1 |
| Gallagher, PJ | 1 |
| O'Leary, S | 1 |
| Shoyele, S | 1 |
| Keane, J | 1 |
| Cryan, SA | 1 |
| de Faria, TJ | 1 |
| Roman, M | 1 |
| de Souza, NM | 1 |
| De Vecchi, R | 1 |
| de Assis, JV | 1 |
| dos Santos, AL | 1 |
| Bechtold, IH | 1 |
| Winter, N | 1 |
| Soares, MJ | 1 |
| Silva, LP | 1 |
| De Almeida, MV | 1 |
| Báfica, A | 1 |
| Somashekar, BS | 1 |
| Amin, AG | 1 |
| Tripathi, P | 1 |
| MacKinnon, N | 1 |
| Rithner, CD | 1 |
| Shanley, CA | 1 |
| Basaraba, R | 1 |
| Henao-Tamayo, M | 1 |
| Kato-Maeda, M | 1 |
| Ramamoorthy, A | 1 |
| Orme, IM | 1 |
| Ordway, DJ | 1 |
| Chatterjee, D | 1 |
| Ul-Ain, Q | 1 |
| Sharma, S | 1 |
| Khuller, GK | 1 |
| RINDT, E | 1 |
| BRUN, J | 1 |
| REVOL, A | 1 |
| BIOT, N | 1 |
| PERRIN-FAYOLLE, M | 1 |
| GARDERE, J | 1 |
| OTRZONSEK, N | 1 |
| KOSTRZEWSKA, K | 1 |
| SCARPA, A | 1 |
| GRASSO, S | 1 |
| Ruberti, M | 1 |
| De Melo, LK | 1 |
| Dos Santos, SA | 2 |
| Brandao, IT | 2 |
| Júnior, JM | 1 |
| Lima, VM | 1 |
| Bonato, VL | 1 |
| Lima, KM | 1 |
| Dos Santos, RR | 1 |
| Gonçalves, ED | 1 |
| Faccioli, LH | 1 |
| Rodrigues-Junior, JM | 1 |
| Kubota, O | 1 |
| Nishimura, K | 1 |
| Inoue, Y | 1 |
| Akutsu, H | 1 |
| Mizuno, H | 1 |
1 trial available for lactic acid and Pulmonary Consumption
| Article | Year |
|---|---|
A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.
Topics: Acidosis, Lactic; Adult; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lactic Acid | 2018 |
13 other studies available for lactic acid and Pulmonary Consumption
| Article | Year |
|---|---|
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization.
Topics: Animals; Bronchoscopy; Dogs; Female; Lactic Acid; Linezolid; Microspheres; Particle Size; Polyglycol | 2017 |
Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Disease Models, Animal; Drug Carriers; Drug | 2012 |
Therapeutic aerosol bioengineering of targeted, inhalable microparticle formulations to treat Mycobacterium tuberculosis (MTb).
Topics: Aerosols; Antitubercular Agents; Cell Line; Drug Carriers; Drug Design; Humans; Lactic Acid; Microsc | 2012 |
An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.
Topics: Animals; Antitubercular Agents; Biological Availability; Cells, Cultured; Drug Compounding; Drug Del | 2012 |
Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis.
Topics: Acetates; Adenosine Monophosphate; Animals; Choline; Epidemics; Ethanolamine; Formates; Glutamic Aci | 2012 |
Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Area Under Curve; Biocompatible Materia | 2003 |
[Lactic acid in relation to pulmonary tuberculosis. A contribution to the problem of rest cure].
Topics: Lactic Acid; Rest; Thoracic Cavity; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[THE BLOOD LACTIC ACID DURING RESPIRATORY INSUFFICIENCY].
Topics: Blood Chemical Analysis; Bronchiectasis; Bronchitis; Humans; Lactates; Lactic Acid; Pneumoconiosis; | 1963 |
[ACTIVITY OF LACTIC ACID DEHYDROGENASE (SLDH) AND OF AMINOTRANSFERASES (SGOT AND SGPT) IN THE BLOOD SERUM IN PRIMARY PULMONARY CANCER AND TUBERCULOSIS].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Chemical Analysis; Clinical Enzyme Tests; D | 1963 |
[Lactacidemia in various evolutive manifestations of pulmonary tuberculosis].
Topics: Blood; Humans; Lactic Acid; Tuberculosis; Tuberculosis, Pulmonary | 1951 |
Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention.
Topics: Animals; Antibodies, Bacterial; Bacterial Proteins; Chaperonin 60; Chaperonins; Cytokines; Immunizat | 2004 |
Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.
Topics: Animals; Cells, Cultured; Cord Factors; Cytokines; Drug Carriers; Inflammation; Lactic Acid; Leukocy | 2001 |
[The metabolic index of nocturnal hypoxia in patients after lung resection and thoracoplasty].
Topics: Aged; Coenzymes; Creatinine; Female; Humans; Lactates; Lactic Acid; Male; Middle Aged; Pneumonectomy | 1991 |